VANGUARD EUROPEAN STOCK INDEX FUND
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS · 5 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
VANGUARD EUROPEAN STOCK INDEX FUND is a developed international equity index ETF that tracks the FTSE Developed Europe All Cap Index.
- Asset class
- Equity
- Region
- Developed international
- Management
- Index (passive)
- Fund type
- ETF
Fund profile
As filed in the prospectus · 2026 Q1
Vanguard European Stock Index Fund (the Fund) seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in the major markets of Europe.
The fund holds the stocks that make up the FTSE Developed Europe All Cap Index in the same proportions, using a replication method to track the index's performance.
| Share class | Expense ratio |
|---|---|
| VEURX | 0.23% |
| VEUSX | 0.08% |
| VESIX | 0.06% |
| VGK | 0.06% |
| VEUPX | 0.05% |
Portfolio turnover 5.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 99.39% |
| Cash & short-term | 0.74% |
| Derivatives | 0.02% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, SUNB, Abivax SA, Zegona Communications plc, HAL Trust, Kongsberg Maritime AS, Berner Kantonalbank AG, B&M European Value Retail plc
Largest exited: Roche Holding AG, Ashtead Group PLC, JDE Peet's NV, Just Group PLC, B&M European Value Retail SA, Iberdrola SA, Banca Popolare di Sondrio SPA, Dowlais Group PLC
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +23.13% | +51.41% | +54.86% | 13.78% | -11.04% | |
| +23.32% | +52.03% | +55.85% | 13.79% | -11.01% | |
| +23.34% | +52.12% | +56.02% | 13.80% | -11.00% | |
| +23.34% | +52.13% | +55.99% | 13.79% | -11.00% | |
| +23.36% | +52.17% | +56.10% | 13.80% | -11.00% |
These classes hold the same portfolio, so the 1.24pp spread over 5 years is the cost difference between them — roughly 0.25pp a year — not a difference in what they own.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| ASMLF | ASML Holding NVASMLF | 3.61% | $1,445.55 | $1.36B | 944.0K |
| — | HSBC Holdings PLC | 2.03% | $18.40 | $768.80M | 41.8M |
| — | Roche Holding AG | 1.84% | $407.50 | $696.40M | 1.7M |
| — | AstraZeneca PLC | 1.83% | $189.72 | $691.95M | 3.6M |
| NVSEF | Novartis AGNVSEF | 1.83% | $147.79 | $690.25M | 4.7M |
| NSRGF | Nestle SANSRGF | 1.68% | $101.24 | $633.90M | 6.3M |
| — | Shell PLC | 1.67% | $45.44 | $629.27M | 13.8M |
| — | Siemens AG | 1.41% | $297.16 | $530.95M | 1.8M |
| — | Banco Santander SA | 1.15% | $12.20 | $434.58M | 35.6M |
| — | Allianz SE | 1.12% | $456.73 | $422.90M | 925.9K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.
Top 10 positions are 18.16% of net assets, top 25 31.98%, across 1.2K issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free